Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...
During their conversation, Lloyd told Sandell that he was feeling "pretty good." In addition to schizophrenia, Lisa previously told Sandell that Lloyd also has a neurological condition known as ...